DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)
$103.16 1.55 (1.5254%)
Analysed DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) News Sources
Stocks Fall on Weakness in Tech and Trucking Companies
10-06-2026
barchart.com
Stocks Resume Decline as Chipmakers and AI Companies Fall
10-06-2026
barchart.com
Stocks Settle Sharply Lower on Escalating Middle East Tensions
10-06-2026
barchart.com
Sanofi, An Argenx Rival, Bites The Dust — But A Third Biotech Took The Biggest Hit
10-06-2026
yahoo.com
DNTH Stock Clocks Best Day In Over 3 Months On Strong Nerve Disorder Study Results
12-06-2026
stocktwits.com
Dianthus CIDP Data Lift Prospects While Funding And Dilution Risks Linger
15-06-2026
yahoo.com
DNTH Shares Surge 89% Over the Past Six Months: What's Driving It?
17-06-2026
yahoo.com
Chronic Inflammatory Demyelinating Polyneuropathy Market Gains Traction During the Forecast Period (2026-2036) with Advancing Clinical Research Activities | DelveInsight
18-06-2026
yahoo.com
Dianthus Therapeutics Announces Initiation of Phase 3 Emerge Trial of Claseprubart in Generalized Myasthenia Gravis
29-06-2026
yahoo.com
Dianthus Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(C)(4)
02-07-2026
yahoo.com
What is the current price of DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)?
The current price of DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) is $103.16.
DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) absolute price change since previous trading day?
The absolute price change of DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) since the previous trading day is $1.55.
DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) percentage price change since previous trading day?
The percentage price change of DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) since the previous trading day is 1.5254%.
What is the most recent average sentiment score for DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)?
The most recent average sentiment score for DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) is 51 out of 100.
What is the most recent average sentiment for DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)?
The most recent sentiment for DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ) is .
SEC-8K** Filing Available For DIANTHUS THERAPEUTICS INC (DNTH:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.